FDA announced on July 10, 2020 that it was planning to restart inspections of domestic facilities the week of July 20, dependent on the trajectory of the virus in the state the facility is located as well as local government rules and guidelines. On-site surveillance inspections of US facilities were put on hold in March 2020 because of the COVID-19 pandemic.
In a statement, FDA Commissioner Stephen M. Hahn, MD said the agency has been monitoring federal, state, and county level reopening criteria to identify where and when domestic facility inspections can resume based on risk factors.
